HK1223975A1 - Nanobubble-containing composition and use thereof - Google Patents

Nanobubble-containing composition and use thereof

Info

Publication number
HK1223975A1
HK1223975A1 HK16112319.1A HK16112319A HK1223975A1 HK 1223975 A1 HK1223975 A1 HK 1223975A1 HK 16112319 A HK16112319 A HK 16112319A HK 1223975 A1 HK1223975 A1 HK 1223975A1
Authority
HK
Hong Kong
Prior art keywords
nanobubble
containing composition
composition
Prior art date
Application number
HK16112319.1A
Other languages
Chinese (zh)
Inventor
亀井郎
Original Assignee
Aqua Zest Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aqua Zest Corp filed Critical Aqua Zest Corp
Publication of HK1223975A1 publication Critical patent/HK1223975A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/54—Mixing with gases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/40—Foaming or whipping
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Environmental Sciences (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
HK16112319.1A 2013-12-27 2016-10-26 Nanobubble-containing composition and use thereof HK1223975A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013273610 2013-12-27
JP2014212676 2014-10-17
PCT/JP2015/050073 WO2015099201A1 (en) 2013-12-27 2015-01-05 Nanobubble-containing composition and use thereof

Publications (1)

Publication Number Publication Date
HK1223975A1 true HK1223975A1 (en) 2017-08-11

Family

ID=53479037

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112319.1A HK1223975A1 (en) 2013-12-27 2016-10-26 Nanobubble-containing composition and use thereof

Country Status (4)

Country Link
JP (1) JP2016063804A (en)
CN (1) CN105593363A (en)
HK (1) HK1223975A1 (en)
WO (1) WO2015099201A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6787585B2 (en) * 2016-01-21 2020-11-18 国立大学法人大阪大学 Cell culture method
CN108778293A (en) * 2016-03-06 2018-11-09 水活力株式会社 Osteanagenesis composition for promoting and osteanagenesis promote device
CN109415686B (en) * 2016-05-13 2023-02-21 株式会社希古玛科技 Aqueous solution for administration to living body and method for producing the same
JP6129395B1 (en) * 2016-10-29 2017-05-17 誠一 荒木 Reduced vitamin B2 preparation for recovery and protection of vascular endothelial cells caused by mitochondrial activation
JP7149053B2 (en) * 2017-04-25 2022-10-06 株式会社田中金属製作所 Liquids for prevention or improvement of diabetes
CN110227363A (en) * 2018-03-06 2019-09-13 四季洋圃生物机电股份有限公司 Multi-functional ultramicro air bubble water implementation method and its manufacturing device
KR20210136177A (en) * 2018-05-30 2021-11-16 가부시키가이샤 아쿠아솔루션 Method of controlling powdery mildew
EP3794943A4 (en) * 2018-05-31 2022-05-11 Aichi Medical University Composition for preserving biomaterial, method for preserving biomaterial, method for producing biomaterial, transplantation material and transplantation method
JP7382602B2 (en) * 2018-05-31 2023-11-17 学校法人 愛知医科大学 Compositions, cell preservation compositions, cell culture compositions, cell preparations, methods for producing objects containing microbubbles, methods for preserving cells, methods for culturing cells, and methods for producing cell preparations
JP7041895B2 (en) * 2018-10-02 2022-03-25 株式会社ファーベスト Mitochondrial activation material, mitochondrial activation composition and mitochondrial activation method
JP6890353B2 (en) * 2019-03-26 2021-06-18 ＭｉＺ株式会社 Composition for improving renal function of renal diseases containing molecular hydrogen
CN114269385A (en) * 2019-06-26 2022-04-01 武田药品工业株式会社 Transfection method
WO2021064995A1 (en) * 2019-10-04 2021-04-08 フレンド株式会社 Evaluation method and evaluation system for efficacy of hydrogen mixed gas on living organism
EP4042868A4 (en) * 2019-10-08 2023-10-25 Iwatani Corporation Composition for freezing cells, method for freezing cells, method for culturing cells, and kit for freezing cells
JP6760630B1 (en) * 2019-10-29 2020-09-23 学校法人 愛知医科大学 A method for producing a microbubble-containing electrolyte solution and a method for producing a microbubble-containing solvent used for preparing a microbubble-containing electrolyte solution.
JP6828918B1 (en) * 2019-10-30 2021-02-10 浩平 池田 Survival improver after resumption of self-heartbeat after cardiac arrest
CN116134130A (en) * 2020-07-20 2023-05-16 学校法人爱知医科大学 Composition for maintaining and culturing pluripotent cells in undifferentiated state, culture medium for maintaining and culturing pluripotent cells in undifferentiated state, and method for producing pluripotent cells
CN111919990A (en) * 2020-08-04 2020-11-13 上海华鹿环保技术中心 Pure natural nano bubble fresh-keeping water and preparation method thereof
CN111972399B (en) * 2020-08-06 2021-11-30 温州医科大学 Preservation solution for maintaining activity of liver cells
CN113209847A (en) * 2021-06-11 2021-08-06 同济大学 Sterile nano bubble water and preparation method and application thereof
CN114469758B (en) * 2022-01-25 2024-02-20 中国科学院上海应用物理研究所 Small-particle-size nano bubble water and preparation method and application thereof
CN114600872A (en) * 2022-04-13 2022-06-10 西安北光医学生物技术有限公司 Method and system for anti-damage preservation of cells, tissues or organs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5120998B2 (en) * 2006-09-06 2013-01-16 国立大学法人 東京医科歯科大学 Tissue, cell or organ preservation solution
JP2008156320A (en) * 2006-12-26 2008-07-10 Hydrox Kk Antioxidative functional water
JP2009082903A (en) * 2007-09-16 2009-04-23 Sgk Kk Microbubble generator
JP4921332B2 (en) * 2007-11-29 2012-04-25 株式会社Ｒｅｏ研究所 Method for producing nitrogen nanobubble water
JP2009195889A (en) * 2008-02-25 2009-09-03 Opt Creation:Kk Apparatus for manufacturing nanobubble liquid
JP4594996B2 (en) * 2008-05-02 2010-12-08 株式会社 シンワ Food sterilization method and apparatus using microbubble mixed sodium hypochlorite diluent
JP5773473B2 (en) * 2008-09-01 2015-09-02 田中　裕之 NK activity enhancer and use thereof
MX2011011333A (en) * 2009-04-27 2011-11-18 Revalesio Corp Compositions and methods for treating insulin resistance and diabetes mellitus.
JP2011078371A (en) * 2009-10-09 2011-04-21 Tomotaka Marui Micro-bubble-containing composition for promoting cell variation, apparatus for producing the same, and method for promoting cell variation using micro-bubble-containing composition
CN107088374A (en) * 2010-04-30 2017-08-25 Hrd有限公司 High shear force application in medicine delivery
JP5319607B2 (en) * 2010-05-31 2013-10-16 丸井 智敬 Liquid composition containing microbubbles and method for producing composition containing microbubbles

Also Published As

Publication number Publication date
WO2015099201A1 (en) 2015-07-02
JP2016063804A (en) 2016-04-28
CN105593363A (en) 2016-05-18

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and uses thereof
HK1223975A1 (en) Nanobubble-containing composition and use thereof
GB201317286D0 (en) Composition and Use
ZA201602510B (en) Strigolactone formulations and uses thereof
EP2953474A4 (en) Compositions and methods
GB201313423D0 (en) Compositions and methods
GB201308072D0 (en) Compositions and methods
GB201305277D0 (en) Novel combination and use
PT3077467T (en) Drier composition and use thereof
GB201321693D0 (en) Composition and uses thereof
GB201323008D0 (en) Compounds and uses thereof
IL240248A0 (en) Met-binding agents and uses thereof
IL276126B (en) Compositions comprising l-4-chlorokynurenine and uses thereof
GB201305813D0 (en) Compositions and methods
EP3007720A4 (en) Compositions comprising gc- macrophage activating factor and uses thereof
IL240553A0 (en) Il-1ß inhibitor composition and use thereof
SG11201510150VA (en) Immunotherapy composition and use thereof
PL2910131T3 (en) Anti-fatigue composition and use thereof
GB201307233D0 (en) Compounds and uses thereof
EP2964610A4 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
GB201301979D0 (en) New composition and use thereof
GB201307989D0 (en) Novel combinations and use
GB201318151D0 (en) Composition and device
GB201322892D0 (en) Surface and composition
GB201305297D0 (en) Novel agents and uses thereof